MARCELLA PATRICO: Open Payments
NPI 1154974418 · TROY, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$416 in 21 payments from 11 companies in 2025. Trend: 2023 $317 · 2024 $104 · 2025 $416
Food & beverage: $416
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $165 |
| Corcept Therapeutics | 3 | $70 |
| Exact Sciences Corporation | 2 | $42 |
| Otsuka America Pharmaceutical, Inc. | 1 | $22 |
| GlaxoSmithKline, LLC. | 1 | $20 |
| Lilly USA, LLC | 1 | $20 |
| Amgen Inc. | 1 | $17 |
| Actelion Pharmaceuticals US, Inc. | 1 | $16 |
| ABBVIE INC. | 1 | $15 |
| Ethicon Inc. | 1 | $14 |
Products named: Ozempic, Korlym, Rybelsus, REXULTI, Cologuard Collection Kit, The Cologuard Plus Collection Kit, TRELEGY ELLIPTA, KISUNLA.
Industry payments across MI — which companies pay providers there.
